1. RETRACTED ARTICLE: Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients
   Yushuang Luo et al, 2014, European Journal of Medical Research CrossRef
2. miR-107 reverses the multidrug resistance of gastric cancer by targeting the CGA/EGFR/GATA2 positive feedback circuit
   Pei Wang et al, 2024, Journal of Biological Chemistry CrossRef
3. Pulmonary Resection for Metastatic Gastric Cancer
   Yoshihito Iijima et al, 2016, Annals of Thoracic and Cardiovascular Surgery CrossRef
4. Gene’S Co-Expression Network and Experimental Validation of Molecular Markers Associated with The Drug Resistance of Gastric Cancer
   Wenqian Qi et al, 2020, Biomarkers in Medicine CrossRef
5. Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel
   Bo Jin et al, 2015, Cell Biochemistry and Biophysics CrossRef
6. Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation
   Hao Zhang et al, 2016, Scientific Reports CrossRef
7. GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer
   Beiqin Yu et al, 2017, Oncotarget CrossRef
8. A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
   Zhihao Lu et al, 2018, Gastric Cancer CrossRef
9. The role of GLI2 - ABCG2 signaling axis for 5Fu resistance in gastric cancer
   Beiqin Yu et al, 2017, Journal of Genetics and Genomics CrossRef
10. Nanomedicine in Gastric Cancer
    Nayla Mouawad et al, 2019, Gastric Cancer In The Precision Medicine Era CrossRef